-
VoicePort expands automated solutions that support patient care
Though VoicePort’s best-known offering is its PharmaPhonetics platform — which provides multichannel, automated and personalized communications to help pharmacies engage with patients — the Rochester, N.Y.-based company has expanded its offerings as the pharmacist’s role has expanded beyond filling prescriptions to helping patients lead healthy lives.
-
FDA approves Jentadueto XR from Boehringer Ingelheim, Lilly
SILVER SPRING, Md. — The Food and Drug Administration has approved Boehringer Ingelheim and Eli Lilly and Co.’s Jentadueto XR (linagliptin and metformin HCl) tablets, the companies announced Tuesday.The new drug is indicated as a once-daily adjunctive treatment for Type 2 diabetes and works by increasing hormones that stimulate insulin production in the pancreas and that stimulate the liver to produce less glucose.
